Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
News headlines Recursion Pharmaceuticals reported mixed Q2 results, with revenue falling to $7.67 million but narrowing net losses. The company highlighted significant clinical milestones, including ...
At close: August 13 at 4:00:01 PM EDT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results